Blog

Keeping the Lid on R&D Costs

Visual Assay Founder, Mannix Aklian, Featured in Two-Part Series by Drug Discovery & Development:

In the past, pharmaceutical companies bolstered profits with billion-dollar blockbuster drugs that treated large populations for common conditions. But with patents running out, and development costs soaring, that business model may no longer be sustainable.

READ FULL STORY HERE